Brand-name patent losses raise pharma cost concerns

Several brand-name pharmaceuticals will lose patent protection this year. What does this mean for costs? Find out.

Benzodiazepine Rx concerns: Are too many prescribed?

The tremendous expenditure for benzodiazepines has some wondering why so many of these drugs are being prescribed. Find out more.

Predictions for the future of high-cost specialty drugs

An IMS Health expert predicts future drug spending trends and ways to curb rising costs. Read more.

MOST POPULAR IN PHARMACY

PCSK9 inhibitor benefits patients with statin intolerance

May 04, 2016

National Managed Care Pharmacy Survey 2016

Your input is needed! Managed Healthcare Executive, in partnership with Access Market Intelligence and the National Institute of Collaborative Healthcare, is seeking your opinion on the current state of pharmacy. Take the survey and you could win a $200 Visa gift card. Answer Now.

Get the free app!

Part of the

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply.
Please use the links provided if you have questions or concerns regarding this email or your subscription.

This email was sent by: %%Member_Busname%%
%%Member_Addr%%
%%Member_City%%, %%Member_State%%, %%Member_PostalCode%%, %%Member_Country%%

NEWSLETTER

Forward to a Friend
Privacy Statement
Terms of Service
Update Profile
Add/Remove Newsletters
Contact Us